Literature DB >> 1567097

Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital.

C S Landefeld1, P A Anderson.   

Abstract

OBJECTIVE: To test the efficacy of consultation designed to prevent anticoagulant-related bleeding.
DESIGN: Randomized, controlled trial.
SETTING: A large teaching hospital. PATIENTS: A total of 101 patients at increased (greater than 15%) risk for major, in-hospital bleeding while starting long-term anticoagulant therapy who were identified using a validated prediction rule.
INTERVENTIONS: Fifty-five patients received usual care under the direction of the attending physician who had initiated anticoagulant therapy. Forty-six patients received guideline-based consultation in addition to usual care. Guideline-based consultation included individualized review of the risks and benefits of anticoagulant therapy and, on the basis of current practice guidelines, recommendations for daily management. MEASUREMENTS: The main outcome was in-hospital bleeding, which was classified using a reliable, explicit index.
RESULTS: Major or minor bleeding occurred in 17 of 55 patients (31%) receiving usual care alone, compared with 6 of 46 patients (13%) receiving consultation in addition to usual care (P = 0.03). The protective efficacy of consultation was 58% (95% CI, 3% to 82%). Consultation was associated with similar reductions in the frequencies of major bleeding (from 13% to 4%) and minor bleeding (from 18% to 9%). Consultative recommendations had an 84% compliance rate and directly affected anticoagulant management: In the consult group, nonsteroidal anti-inflammatory agents were stopped in six patients (13%), and therapeutic ranges were achieved more often for activated partial thromboplastin times (52% compared with 45% in the usual care group, P = 0.08) and for prothrombin times (47% compared with 27% in the usual care group, P less than 0.001). Nearly all housestaff and attending physicians (91%) for patients receiving consultation also reported that consultation improved housestaff learning. The consult group had a somewhat lower rate of thromboembolism in the 90 days after discharge (5% compared with 17%, P = 0.06). Death rates and mean lengths of stay were similar in the two groups.
CONCLUSION: Guideline-based consultation was associated with reduction in the frequency of anticoagulant-related bleeding in patients at increased risk for major in-hospital bleeding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567097     DOI: 10.7326/0003-4819-116-10-829

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST).

Authors:  D B Matchar; G P Samsa; S J Cohen; E Z Oddone
Journal:  J Thromb Thrombolysis       Date:  2000-06       Impact factor: 2.300

Review 2.  Detecting adverse events using information technology.

Authors:  David W Bates; R Scott Evans; Harvey Murff; Peter D Stetson; Lisa Pizziferri; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2003 Mar-Apr       Impact factor: 4.497

Review 3.  Internal medicine training in the inpatient setting. A review of published educational interventions.

Authors:  Lorenzo Di Francesco; Michael J Pistoria; Andrew D Auerbach; Robert J Nardino; Eric S Holmboe
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

Review 4.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

6.  Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?

Authors:  R J Beyth; M R Antani; K E Covinsky; D G Miller; M M Chren; L M Quinn; C S Landefeld
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

7.  Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Authors:  Andrew Frazer; James Rowland; Alison Mudge; Michael Barras; Jennifer Martin; Peter Donovan
Journal:  Eur J Clin Pharmacol       Date:  2019-09-11       Impact factor: 2.953

Review 8.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

9.  A computerized intervention to improve timing of outpatient follow-up: a multicenter randomized trial in patients treated with warfarin. National Consortium of Anticoagulation Clinics.

Authors:  S D Fihn; M B McDonell; D Vermes; J G Henikoff; D C Martin; C M Callahan; D L Kent; R H White
Journal:  J Gen Intern Med       Date:  1994-03       Impact factor: 5.128

10.  Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment.

Authors:  C P Choudari; C Rajgopal; K R Palmer
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.